Mass and controlled fabrication of aligned PVP fibers for matrix type antibiotic drug delivery systems

Li Wang, Ming Wei Chang, Zeeshan Ahmad, Hongxia Zheng, Jing Song Li

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Recent advances in fiber technology and engineering, for nano- and micro-meter scaled materials, have focused largely on developments surrounding the electrospinning (ES) technique. Although this process enables the engineering of complex fibrous structures; the inability to yield industrial scale production through existing ES techniques becomes a bottle-neck and critical feature. Furthermore, in several advanced engineering remits (such as healthcare) the role of fiber alignment, layering and morphology is also paramount. In this study the development of a enhanced spinneret device for the up-scaled production of aligned fibers is demonstrated. Compared to conventional centrifugal electrospinning (CES) techniques, a relatively greater production rate of fibers is achieved at reduced rotation speeds and also excludes the use of needles during the process. The impact of experimental process parameters such as rotation speed (60–90 rpm), working distance (9–14 cm) and solution concentration (15–30 w/v%) on resulting fiber properties were investigated using commercial polymeric drug delivery excipient polyvinyl pyrrolidone (PVP). Mass production of fibers is demonstrated and the impact of specifically aligned ultrafine drug-fiber matrices on drug release behavior is shown. For this, the antibiotic tetracycline hydrogen chloride was spun alongside PVP (5 w/w%) as the matrix material. The spinneret device provides an enhanced approach for active embedded fiber production on a scale favorable to industry (120 g/h) when using optimized process parameters (70 rpm and 15 kV for the four-pore system). Furthermore, the in-situ method permits control on fiber alignment and overall mat thickness providing tailored fabrication for specific applications or drug dosage requirements (e.g. active dissolution behavior for fibrous drug delivery systems).

LanguageEnglish
Pages661-669
Number of pages9
JournalChemical Engineering Journal
Volume307
Early online date31 Aug 2016
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Polyvinyls
Pyrrolidinones
Antibiotics
antibiotics
drug
Anti-Bacterial Agents
Fabrication
matrix
Fibers
Electrospinning
engineering
Drug dosage
Drug Delivery Systems
fibre
Hydrochloric Acid
Excipients
Bottles
Tetracycline
Drug delivery
Pharmaceutical Preparations

Keywords

  • Antibiotics
  • Drug delivery
  • High-aligned
  • Multi-layer
  • Patterning
  • Spinneret

Cite this

Wang, Li ; Chang, Ming Wei ; Ahmad, Zeeshan ; Zheng, Hongxia ; Li, Jing Song. / Mass and controlled fabrication of aligned PVP fibers for matrix type antibiotic drug delivery systems. In: Chemical Engineering Journal. 2017 ; Vol. 307. pp. 661-669.
@article{dea63449a68f4f3eb60931a514cb855a,
title = "Mass and controlled fabrication of aligned PVP fibers for matrix type antibiotic drug delivery systems",
abstract = "Recent advances in fiber technology and engineering, for nano- and micro-meter scaled materials, have focused largely on developments surrounding the electrospinning (ES) technique. Although this process enables the engineering of complex fibrous structures; the inability to yield industrial scale production through existing ES techniques becomes a bottle-neck and critical feature. Furthermore, in several advanced engineering remits (such as healthcare) the role of fiber alignment, layering and morphology is also paramount. In this study the development of a enhanced spinneret device for the up-scaled production of aligned fibers is demonstrated. Compared to conventional centrifugal electrospinning (CES) techniques, a relatively greater production rate of fibers is achieved at reduced rotation speeds and also excludes the use of needles during the process. The impact of experimental process parameters such as rotation speed (60–90 rpm), working distance (9–14 cm) and solution concentration (15–30 w/v{\%}) on resulting fiber properties were investigated using commercial polymeric drug delivery excipient polyvinyl pyrrolidone (PVP). Mass production of fibers is demonstrated and the impact of specifically aligned ultrafine drug-fiber matrices on drug release behavior is shown. For this, the antibiotic tetracycline hydrogen chloride was spun alongside PVP (5 w/w{\%}) as the matrix material. The spinneret device provides an enhanced approach for active embedded fiber production on a scale favorable to industry (120 g/h) when using optimized process parameters (70 rpm and 15 kV for the four-pore system). Furthermore, the in-situ method permits control on fiber alignment and overall mat thickness providing tailored fabrication for specific applications or drug dosage requirements (e.g. active dissolution behavior for fibrous drug delivery systems).",
keywords = "Antibiotics, Drug delivery, High-aligned, Multi-layer, Patterning, Spinneret",
author = "Li Wang and Chang, {Ming Wei} and Zeeshan Ahmad and Hongxia Zheng and Li, {Jing Song}",
note = "Ming-Wei was employed in China on the acceptance and publication dates. The article appears on De Montfort University's Repository (https://www.dora.dmu.ac.uk/handle/2086/12859)",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.cej.2016.08.135",
language = "English",
volume = "307",
pages = "661--669",
journal = "Chemical Engineering Journal",
issn = "1385-8947",
publisher = "Elsevier",

}

Mass and controlled fabrication of aligned PVP fibers for matrix type antibiotic drug delivery systems. / Wang, Li; Chang, Ming Wei; Ahmad, Zeeshan; Zheng, Hongxia; Li, Jing Song.

In: Chemical Engineering Journal, Vol. 307, 01.01.2017, p. 661-669.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mass and controlled fabrication of aligned PVP fibers for matrix type antibiotic drug delivery systems

AU - Wang, Li

AU - Chang, Ming Wei

AU - Ahmad, Zeeshan

AU - Zheng, Hongxia

AU - Li, Jing Song

N1 - Ming-Wei was employed in China on the acceptance and publication dates. The article appears on De Montfort University's Repository (https://www.dora.dmu.ac.uk/handle/2086/12859)

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Recent advances in fiber technology and engineering, for nano- and micro-meter scaled materials, have focused largely on developments surrounding the electrospinning (ES) technique. Although this process enables the engineering of complex fibrous structures; the inability to yield industrial scale production through existing ES techniques becomes a bottle-neck and critical feature. Furthermore, in several advanced engineering remits (such as healthcare) the role of fiber alignment, layering and morphology is also paramount. In this study the development of a enhanced spinneret device for the up-scaled production of aligned fibers is demonstrated. Compared to conventional centrifugal electrospinning (CES) techniques, a relatively greater production rate of fibers is achieved at reduced rotation speeds and also excludes the use of needles during the process. The impact of experimental process parameters such as rotation speed (60–90 rpm), working distance (9–14 cm) and solution concentration (15–30 w/v%) on resulting fiber properties were investigated using commercial polymeric drug delivery excipient polyvinyl pyrrolidone (PVP). Mass production of fibers is demonstrated and the impact of specifically aligned ultrafine drug-fiber matrices on drug release behavior is shown. For this, the antibiotic tetracycline hydrogen chloride was spun alongside PVP (5 w/w%) as the matrix material. The spinneret device provides an enhanced approach for active embedded fiber production on a scale favorable to industry (120 g/h) when using optimized process parameters (70 rpm and 15 kV for the four-pore system). Furthermore, the in-situ method permits control on fiber alignment and overall mat thickness providing tailored fabrication for specific applications or drug dosage requirements (e.g. active dissolution behavior for fibrous drug delivery systems).

AB - Recent advances in fiber technology and engineering, for nano- and micro-meter scaled materials, have focused largely on developments surrounding the electrospinning (ES) technique. Although this process enables the engineering of complex fibrous structures; the inability to yield industrial scale production through existing ES techniques becomes a bottle-neck and critical feature. Furthermore, in several advanced engineering remits (such as healthcare) the role of fiber alignment, layering and morphology is also paramount. In this study the development of a enhanced spinneret device for the up-scaled production of aligned fibers is demonstrated. Compared to conventional centrifugal electrospinning (CES) techniques, a relatively greater production rate of fibers is achieved at reduced rotation speeds and also excludes the use of needles during the process. The impact of experimental process parameters such as rotation speed (60–90 rpm), working distance (9–14 cm) and solution concentration (15–30 w/v%) on resulting fiber properties were investigated using commercial polymeric drug delivery excipient polyvinyl pyrrolidone (PVP). Mass production of fibers is demonstrated and the impact of specifically aligned ultrafine drug-fiber matrices on drug release behavior is shown. For this, the antibiotic tetracycline hydrogen chloride was spun alongside PVP (5 w/w%) as the matrix material. The spinneret device provides an enhanced approach for active embedded fiber production on a scale favorable to industry (120 g/h) when using optimized process parameters (70 rpm and 15 kV for the four-pore system). Furthermore, the in-situ method permits control on fiber alignment and overall mat thickness providing tailored fabrication for specific applications or drug dosage requirements (e.g. active dissolution behavior for fibrous drug delivery systems).

KW - Antibiotics

KW - Drug delivery

KW - High-aligned

KW - Multi-layer

KW - Patterning

KW - Spinneret

UR - http://www.scopus.com/inward/record.url?scp=84985920205&partnerID=8YFLogxK

U2 - 10.1016/j.cej.2016.08.135

DO - 10.1016/j.cej.2016.08.135

M3 - Article

VL - 307

SP - 661

EP - 669

JO - Chemical Engineering Journal

T2 - Chemical Engineering Journal

JF - Chemical Engineering Journal

SN - 1385-8947

ER -